Association Between Endothelial Dysfunction, Biomarkers of Renal Function, and Disease Severity in Sickle Cell Disease

Overview

Journal Kidney360

Specialty Nephrology

Date 2022 Apr 4

PMID 35372907

Authors

Oluwagbemiga Oluwole Ayoola

Rahman Ayodele Bolarinwa

Chidiogo Chukwunweike Onwuka

Bukunmi Michael Idowu

Adeniyi Sunday Aderibigbe

Affiliations

Soon will be listed here.

Abstract

Background: Endothelial dysfunction (ED), as ascertained by brachial artery flow-mediated dilation (FMD), is a known feature of sickle cell disease (SCD), which is present both in crisis and in steady state. The assessment of FMD was introduced to examine the vasodilator function. Our objective was to establish the relationship between ED determined by FMD, biomarkers of renal dysfunction, and biomarkers of disease severity in SCD subjects asymptomatic of renal disease.

Methods: We enrolled 44 patients with homozygous SCD in steady state and 33 age- and sex-matched controls between 2013 and 2014 in a tropical tertiary hospital. Ultrasonographic FMD of the right brachial artery, renal arterial Doppler, complete blood count, creatinine, fetal hemoglobin, soluble P-selectin, and cystatin C (Cys-C) levels were determined. Using the median FMD value of the control group, the SCD subjects were further classified into two groups for comparison.

Results: The median FMD in SCD subjects of 3.44 (IQR, 0.00-7.08) was significantly lower than that of controls, which was 5.35 (IQR, 3.60-6.78; =0.04). There was negative correlation between FMD and Cys-C levels (=-0.372; =0.01) along with renal artery resistivity index (RARI; =-0.307; =0.04) in SCD subjects. Additionally, Cys-C level was significantly higher in SCD subjects with FMD<5.35.

Conclusions: Brachial artery FMD was significantly lower in SCD subjects compared with a control group. Cys-C and RARI show a negative correlation with FMD, indicating that renal function is related to ED in SCD.

Citing Articles

Role of endothelial dysfunction in sleep-disordered breathing in egyptian children with sickle cell disease.

Youssry I, Mostafa A, Hamed D, Hafez Y, Bishai I, Selim Y BMC Pediatr. 2024; 24(1):626.

PMID: 39354381 PMC: 11443814. DOI: 10.1186/s12887-024-05066-6.

Endothelial Dysfunction Linked to Ventricular Dysfunction in Children With Sickle Cell Disease, a 3D Speckle Tracking Study.

AbdelMassih A, Haroun M, AbdelAziz Afifi R, Hussein G, AbdelHameed M, Asaad M J Saudi Heart Assoc. 2024; 36(1):27-33.

PMID: 38873326 PMC: 11172668. DOI: 10.37616/2212-5043.1369.

Relevance of Plasma Homocysteine and Methylenetetrahydrofolate Reductase 677TT Genotype in Sickle Cell Disease: A Systematic Review and Meta-Analysis.

Ames P, Arcaro A, Caruso M, Graf M, Marottoli V, Gentile F Int J Mol Sci. 2022; 23(23).

PMID: 36498990 PMC: 9736045. DOI: 10.3390/ijms232314641.

Clinical Characteristics and Prognosis of Patients with Multi-Vessel Coronary Spasm in Comparison with Those in Patients with Single-Vessel Coronary Spasm.

Teragawa H, Oshita C, Uchimura Y J Cardiovasc Dev Dis. 2022; 9(7).

PMID: 35877566 PMC: 9322607. DOI: 10.3390/jcdd9070204.

References

Hijmans C, Grootenhuis M, Oosterlaan J, Heijboer H, Peters M, Fijnvandraat K . Neurocognitive deficits in children with sickle cell disease are associated with the severity of anemia. Pediatr Blood Cancer. 2011; 57(2):297-302. DOI: 10.1002/pbc.22892. View

Bots M, Westerink J, Rabelink T, de Koning E . Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response. Eur Heart J. 2004; 26(4):363-8. DOI: 10.1093/eurheartj/ehi017. View

Akinsheye I, Klings E . Sickle cell anemia and vascular dysfunction: the nitric oxide connection. J Cell Physiol. 2010; 224(3):620-5. DOI: 10.1002/jcp.22195. View

Aikimbaev K, Oguz M, Guvenc B, Baslamisli F, Kocak R . Spectral pulsed Doppler sonography of renal vascular resistance in sickle cell disease: clinical implications. Br J Radiol. 1996; 69(828):1125-9. DOI: 10.1259/0007-1285-69-828-1125. View

Ponte B, Pruijm M, Ackermann D, Vuistiner P, Eisenberger U, Guessous I . Reference values and factors associated with renal resistive index in a family-based population study. Hypertension. 2013; 63(1):136-42. DOI: 10.1161/HYPERTENSIONAHA.113.02321. View

Adams R, McKie V, Nichols F, Carl E, Zhang D, McKie K . The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med. 1992; 326(9):605-10. DOI: 10.1056/NEJM199202273260905. View

Levey A, Stevens L . Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. Am J Kidney Dis. 2010; 55(4):622-7. PMC: 2846308. DOI: 10.1053/j.ajkd.2010.02.337. View

Coll E, Botey A, Alvarez L, Poch E, Quinto L, Saurina A . Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis. 2000; 36(1):29-34. DOI: 10.1053/ajkd.2000.8237. View

Mosseri M, Wenc K, Isner J, Weinstein R . Inhibition of endothelium-dependent vasorelaxation by sickle erythrocytes. Am Heart J. 1993; 126(2):338-46. DOI: 10.1016/0002-8703(93)91049-k. View

10.

Ogunmoroti O, Ayoola O, Makinde O, Idowu B . Maternal renal artery Doppler sonographic changes in pregnancy-induced hypertension in South West Nigeria. Niger Med J. 2015; 56(3):190-3. PMC: 4518335. DOI: 10.4103/0300-1652.160367. View

11.

ERSLEV A . Humoral regulation of red cell production. Blood. 1953; 8(4):349-57. View

12.

Aslan M, Ryan T, Adler B, Townes T, Parks D, Thompson J . Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proc Natl Acad Sci U S A. 2001; 98(26):15215-20. PMC: 65009. DOI: 10.1073/pnas.221292098. View

13.

Corretti M, Anderson T, Benjamin E, Celermajer D, Charbonneau F, Creager M . Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002; 39(2):257-65. DOI: 10.1016/s0735-1097(01)01746-6. View

14.

Thijssen D, Black M, Pyke K, Padilla J, Atkinson G, Harris R . Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. Am J Physiol Heart Circ Physiol. 2010; 300(1):H2-12. PMC: 3023245. DOI: 10.1152/ajpheart.00471.2010. View

15.

Embury S, Matsui N, Ramanujam S, Mayadas T, Noguchi C, Diwan B . The contribution of endothelial cell P-selectin to the microvascular flow of mouse sickle erythrocytes in vivo. Blood. 2004; 104(10):3378-85. DOI: 10.1182/blood-2004-02-0713. View

16.

Cheuiche A, Queiroz M, Azeredo-da-Silva A, Silveiro S . Performance of Cystatin C-Based Equations for Estimation of Glomerular Filtration Rate in Diabetes Patients: A Prisma-Compliant Systematic Review and Meta-Analysis. Sci Rep. 2019; 9(1):1418. PMC: 6363744. DOI: 10.1038/s41598-018-38286-9. View

17.

Houston P, Rana S, Sekhsaria S, Perlin E, Kim K, Castro O . Homocysteine in sickle cell disease: relationship to stroke. Am J Med. 1997; 103(3):192-6. DOI: 10.1016/s0002-9343(97)00129-0. View

18.

Apoku I, Ayoola O, Salako A, Idowu B . Ultrasound evaluation of obstructive uropathy and its hemodynamic responses in southwest Nigeria. Int Braz J Urol. 2015; 41(3):556-61. PMC: 4752151. DOI: 10.1590/S1677-5538.IBJU.2014.0197. View

19.

Weatherall D, Clegg J . Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001; 79(8):704-12. PMC: 2566499. View

20.

Tharaux P . Endothelin in renal injury due to sickle cell disease. Contrib Nephrol. 2011; 172:185-199. DOI: 10.1159/000328699. View